身体圆度指数与慢性肾脏病患者死亡风险:超越肥胖悖论
本研究基于NHANES数据,纳入6240例CKD患者,中位随访6.6年。身体圆度指数(BRI)与全因及心血管死亡呈J型关联,BRI>10时全因死亡风险aHR 1.82、心血管死亡aHR 2.15,而BMI>30却与死亡风险降低相关。BRI较BMI或腰围对CKD患者风险分层更具预后价值。
要点
- BMI>30与全因和心血管死亡风险分别降低44%和40%相关,提示肥胖悖论。
- BRI>10的死亡风险关联在<65岁或白蛋白尿升高患者中更显著。
核心结论
- 较高的BRI与CKD患者全因和心血管死亡风险增加独立相关。
- BRI对CKD患者风险分层的预后价值优于BMI或腰围。
研究设计与样本
- 观察性研究,利用美国国家健康与营养调查(NHANES)数据。
- 纳入6240例CKD患者,平均年龄63岁,43%为男性,中位随访6.6年。
- BRI由腰围和身高计算,BMI由体重和身高计算;采用限制性立方样条确定BRI最佳截点,Cox比例风险模型分析关联。
主要发现
- 随访期间记录1922例全因死亡和715例心血管死亡。
- 限制性立方样条显示BRI与死亡率呈J型关联。
- 与参考值5.9-6.8相比,BRI>10与全因死亡风险显著增加相关(aHR 1.82,95%CI 1.34-2.47)。
- 与参考值5.9-6.5相比,BRI>10与心血管死亡风险显著增加相关(aHR 2.15,95%CI 1.27-3.62)。
- 与BMI参考值18.5-25相比,BMI>30与全因死亡风险降低44%、心血管死亡风险降低40%相关。
关键数值与推荐
- BRI>10作为CKD患者全因和心血管死亡风险增高的最佳截点。
- BMI>30与死亡风险降低相关,提示肥胖悖论。
临床怎么用
- 在CKD患者中可采用BRI>10识别全因和心血管死亡高风险个体,尤其对于<65岁或白蛋白尿升高者。
- BRI可能较BMI或腰围提供更好的风险分层,辅助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Body roundness index (BRI), an emerging anthropometric measure, has been shown to outperform body mass index (BMI) in predicting mortality risk in the general population. However, its prognostic value among patients with chronic kidney disease (CKD), where the obesity paradox may exist, remains unknown. METHODS: This observational study utilized data from the National Health and Nutrition Examination Survey. BRI was calculated using waist circumference (WC) and height, whereas BMI was calculated using body weight and height. Restricted cubic splines (RCSs) were applied to determine optimal cut-off points of BRI for all-cause and cardiovascular mortality in patients with CKD. Associations were examined using Cox proportional hazards models adjusted for potential confounders. RESULTS: Over a median follow-up of 6.6 years, 6240 patients with CKD (mean age 63 years, 43% men) were included, with 1922 all-cause and 715 cardiovascular deaths recorded. RCSs demonstrated J-shaped associations between BRI with mortality. A BRI >10 was associated with a significantly increased risk of all-cause {adjusted hazard ratio [aHR] 1.82 [95% confidence interval (CI) 1.34-2.47]} and cardiovascular mortality [aHR 2.15 (95% CI 1.27-3.62)] compared with the reference of 5.9-6.8 and 5.9-6.5, respectively, with dose-response trends (P for trend < .05). A BMI >30 was paradoxically associated with 44% and 40% lower risks of all-cause and cardiovascular mortality compared with the reference of 18.5-25, respectively. A WC >125 was associated with an increased risk of all-cause mortality [aHR 2.17 (95% CI 1.47-3.18)] but not with cardiovascular mortality [aHR 1.83 (95% CI 0.97-3.45)] compared with the reference of 95-105 cm. The associations between BRI >10 and mortality risks were particularly pronounced among younger adults <65 years of age or individuals with elevated albuminuria (P for interaction < .05). CONCLUSIONS: Higher BRI was independently associated with increased all-cause and cardiovascular mortality risk among patients with CKD, offering greater prognostic value for risk stratification than BMI or WC.
引用
- Yang C, Liao B, Vart P, et al. Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox. Nephrol Dial Transplant. 2026. PMID: 41206765. doi:10.1093/ndt/gfaf237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。